Descrizione del progetto
Un software innovativo per trattamenti antitumorali migliori e minimamente invasivi
GoSmart è un innovativo software basato sul cloud che formerà i radiologi nell’ambito di trattamenti antitumorali minimamente invasivi e guidati dalle immagini, aiutandoli a pianificare il trattamento ottimale dei pazienti senza alcun rischio in un ambiente virtuale. Ciò condurrà a una terapia più precisa e a processi più efficienti, anche sotto il profilo dei costi, diminuendo al contempo l’impronta di carbonio degli ospedali attraverso la collaborazione e la riduzione dei viaggi. Inoltre, questo ambiente di simulazione consentirà a medici meno esperti di collaborare con colleghi in tutto il mondo. Il progetto SIMCARE, finanziato dall’UE, si propone di introdurre il software sul mercato conducendo uno studio di fattibilità per capirne i requisiti tecnici e commerciali. Inoltre, analizzerà le necessità del mercato e definirà le esigenze normative.
Obiettivo
The objective of this proposal is to assess the potential for commercialisation of an innovative cloud-based software product which will assist interventional radiologists to perform minimally invasive cancer treatments more successfully. There are different approaches to removing tumours in organs (i.e. the liver, kidney and lung) and each has its own advantages and disadvantages, depending on the size and location of the tumour. Minimally invasive cancer treatments offer clear advantages as the procedures are targeted and much less intrusive compared to surgical resection. However, the procedure can be very technical, as the radiologist must understand how the settings of the device affect the heat transfer in the localised region surrounding the tumour. Our software product will bridge this gap and help the radiologist understand how to best perform the treatment within a virtual environment with no risk to the patient. This will bring benefits to the radiological community through more accurate treatments, will make the procedures more efficient and cost-effective, and will reduce the hospital carbon footprint through more integrated collaboration and reduced travel. In addition, as it is web-based, it will help to integrate the global interventional oncology community, providing less experienced clinicians in developing countries with a user-friendly environment to work with their more experienced colleagues on a global basis. During this project, we will enhance our simulation environment and refine our growth projections for the first 8 years on the market. We will also analyse the market needs and define the regulatory requirements for patient data sharing and use of the software in the clinical environment. This information will assist us to understand the most efficient route to bring the software to the market.
Campo scientifico
- medical and health sciencesclinical medicinesurgery
- medical and health sciencesclinical medicineradiology
- medical and health sciencesclinical medicineoncology
- engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging
- natural sciencescomputer and information sciencessoftwaresoftware applicationssimulation software
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEInst-2018-2020-1
Meccanismo di finanziamento
SME-1 - SME instrument phase 1Coordinatore
A91 Dundalk Louth
Irlanda
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.